Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reversal!!! .055 by close today!
$VDRM
Yep! Almost 1,000,000 shares just bought!
$VDRM
Level2 looks good! LOAD TIME people!!
Anyone who know this company, knows we will be trading .10-12+ post conference next week!! Mark this post
$VDRM
Watch this reverse here! Easy .10-12+ this week or next
$VDRM
Perfect LOAD time here! Bounce will happen!!
We will see .10-12+ either this week or next!!
$VDRM
LOOK AT THE LIST OF COMPANIES BELOW!
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
Sponsors
EDUCATIONAL GRANTS
This activity has been planned to be well-balanced, objective, and scientifically rigorous. Information and opinions offered by speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.
Texas Heart Institute, Office of Continuing Medical Education, along with Baylor College of Medicine, gratefully acknowledges the following companies for providing educational grant support for this activity
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
EXHIBITS, SYMPOSIA AND WORKSHOP SPONSORS
Support for this conference has been provided in part by the following exhibitor, symposium and workshop sponsors:
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
FRIENDS OF DFCON
8th International Symposium on the Diabetic Foot
First Nations Limb Preservation Foundation
Wound Healing Society/Wound Healing Foundation
Inquires: dfcon@bcm.edu
Our good DOC speaks on Friday at DFCon. Next week we never see under .10 again!!
http://dfcon.com/
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
BIG BUYS coming in! Time to rip!!!
I expect a close at .055+
$VDRM
EASY 100%+ return coming. Next week we will never see under .10 again.
$VDRM
Time to LOAD here!! Watch this reverse and rip back up
$VDRM
Huh?!? You wouldn't be happy with $1??
I think many investors would like to see us run from .05 to $1!!
Long $VDRM
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
YEP!
LOOK AT THE LIST OF COMPANIES BELOW!
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
Sponsors
EDUCATIONAL GRANTS
This activity has been planned to be well-balanced, objective, and scientifically rigorous. Information and opinions offered by speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.
Texas Heart Institute, Office of Continuing Medical Education, along with Baylor College of Medicine, gratefully acknowledges the following companies for providing educational grant support for this activity
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
EXHIBITS, SYMPOSIA AND WORKSHOP SPONSORS
Support for this conference has been provided in part by the following exhibitor, symposium and workshop sponsors:
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
FRIENDS OF DFCON
8th International Symposium on the Diabetic Foot
First Nations Limb Preservation Foundation
Wound Healing Society/Wound Healing Foundation
Inquires: dfcon@bcm.edu
LOL!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
BOOOOOOOOOOOM
.10-12+ is coming ;)
Our good DOC speaks on Friday at DFCon. Next week we never see under .10 again!!
http://dfcon.com/
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
I just did the same at .25, and will adjust my limit as the share price moves up!
Long $VDRM
Thanks percival77! Mark my words people!!!!
WE WILL FLY AFTER THE CONFERENCE NEXT MONDAY & TUESDAY!! I'M JOKING, BUT I THINK WE COULD RUN TO .25 NEXT WEEK!
LOOK AT THE LIST OF COMPANIES BELOW!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
Sponsors
EDUCATIONAL GRANTS
This activity has been planned to be well-balanced, objective, and scientifically rigorous. Information and opinions offered by speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.
Texas Heart Institute, Office of Continuing Medical Education, along with Baylor College of Medicine, gratefully acknowledges the following companies for providing educational grant support for this activity
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
EXHIBITS, SYMPOSIA AND WORKSHOP SPONSORS
Support for this conference has been provided in part by the following exhibitor, symposium and workshop sponsors:
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
FRIENDS OF DFCON
8th International Symposium on the Diabetic Foot
First Nations Limb Preservation Foundation
Wound Healing Society/Wound Healing Foundation
Inquires: dfcon@bcm.edu
That's why this little ticker is a SCREAMING BUY!!
.10-.12+ this month
.50 by summer
$$'s by year end!!
Long $VDRM
And signed an LOI...
The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.
$VDRM
For once I partially agree with you!! LOL
That's why he hired this guy... BOOOOOOOOM
March 8, 2017
~ Sales, labeling & marketing being launched!! Industry expert hired!! ~
http://www.marketwired.com/press-release/viaderma-inc-hires-product-rollout-expert-manage-quality-control-labeling-marketing-pinksheets-vdrm-2201662.htm
~Ivan Klarich Reviews~
https://www.linkedin.com/in/ivanklarich/
Aidan Roark Makepeace
Founder/CEO at WRKPRTY
Aidan Roark worked with Ivan in different groups
I have had the privilege of working with and for Ivan on several software development and business strategy projects ranging from the start-up to the enterprise level and can say, without reservation, Ivan is amazing to work with. Ivan is a thoughtful and inspiring leader and team-builder, and an energetic, diligent, and reliable visionary in strategic planning and operations/executive management. I welcome every opportunity to work with Ivan and can wholeheartedly recommend his services, as well as those of his extensive team of associates.
Mireille Buiel
HR Lead at FindHotel
Mireille worked with Ivan but at different companies
I have worked together with Ivan as consultants at a California based FMCG manufacturing company. I got to know him as a value-based strategic thinker that keeps his eye on the long-term goal. He is able to bring teams and entrepreneurs quickly to the ‘pain points’ and find new practical solutions for their business (model) issues. I would definitely recommend him for complex organizational and commercial challenges.
John Fanaris
Co-Owner/GM/Sommelier at Rustic Kitchen
John worked with Ivan but at different companies
Preparing for growth and putting the right pieces together are crucial to success and Ivan brings the tools needed to the table. He has a non-confrontational demeanor in his analysis of your internal methodology with the uncanny knack of straight forward communication and a tell-it-like-it-is constructive advice. He is an expert at analyzing company operations and culture to develop a comprehensive strategy to reach your goals. If you are looking to take your company to the next level, Ivan is your man.
Jackie Lapin / Authors, Speakers, Get Leads, Get Booked
?? AUTHORS & SPEAKERS, GET LEADS, GET BOOKED–Book Your Own Speaking Engagements at Transformational Venues & Events
Jackie Lapin / worked with Ivan but at different companies
Ivan is one of the most brilliant forward-thinking business visionaries I've ever encountered. That skill is anchored by real world practical strategic analytics and implementation that ensures success. I want him on my team whenever I'm launching something new, improve what's already working or need to fix something that's not!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129418493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129409088
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402020
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129401494
http://www.hopedance.org/home/awakenings/2920-virtual-realty-enters-the-arena-to-help-people-overcome-their-co-dependency-on-outside-approval-to-achieve-an-emotionally-free-high-performance-happy-life
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129344707
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339497
There is none! ViaDerma has the provisional patent and the technology. No other company on the planet can touch them.
The medical community will see this on Friday at the conference.
$VDRM
Watch the BUYS pour back in!
.10-12+ EOD Friday!!
$VDRM
ViaDerma = $$'s coming this year! Here's all the DD you need to know.
March 20, 2017 08:00 ET
ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries.
The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed
http://www.marketwired.com/press-release/viaderma-receives-provisional-patent-numbers-its-fda-registered-viabecline-cannabis-otc-pink-vdrm-2203945.htm
March 8, 2017
~ Sales, labeling & marketing being launched!! Industry expert hired!! ~
http://www.marketwired.com/press-release/viaderma-inc-hires-product-rollout-expert-manage-quality-control-labeling-marketing-pinksheets-vdrm-2201662.htm
~Ivan Klarich Reviews~
https://www.linkedin.com/in/ivanklarich/
Aidan Roark Makepeace
Founder/CEO at WRKPRTY
Aidan Roark worked with Ivan in different groups
I have had the privilege of working with and for Ivan on several software development and business strategy projects ranging from the start-up to the enterprise level and can say, without reservation, Ivan is amazing to work with. Ivan is a thoughtful and inspiring leader and team-builder, and an energetic, diligent, and reliable visionary in strategic planning and operations/executive management. I welcome every opportunity to work with Ivan and can wholeheartedly recommend his services, as well as those of his extensive team of associates.
Mireille Buiel
HR Lead at FindHotel
Mireille worked with Ivan but at different companies
I have worked together with Ivan as consultants at a California based FMCG manufacturing company. I got to know him as a value-based strategic thinker that keeps his eye on the long-term goal. He is able to bring teams and entrepreneurs quickly to the ‘pain points’ and find new practical solutions for their business (model) issues. I would definitely recommend him for complex organizational and commercial challenges.
John Fanaris
Co-Owner/GM/Sommelier at Rustic Kitchen
John worked with Ivan but at different companies
Preparing for growth and putting the right pieces together are crucial to success and Ivan brings the tools needed to the table. He has a non-confrontational demeanor in his analysis of your internal methodology with the uncanny knack of straight forward communication and a tell-it-like-it-is constructive advice. He is an expert at analyzing company operations and culture to develop a comprehensive strategy to reach your goals. If you are looking to take your company to the next level, Ivan is your man.
Jackie Lapin / Authors, Speakers, Get Leads, Get Booked
?? AUTHORS & SPEAKERS, GET LEADS, GET BOOKED–Book Your Own Speaking Engagements at Transformational Venues & Events
Jackie Lapin / worked with Ivan but at different companies
Ivan is one of the most brilliant forward-thinking business visionaries I've ever encountered. That skill is anchored by real world practical strategic analytics and implementation that ensures success. I want him on my team whenever I'm launching something new, improve what's already working or need to fix something that's not!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129418493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129409088
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402020
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129401494
http://www.hopedance.org/home/awakenings/2920-virtual-realty-enters-the-arena-to-help-people-overcome-their-co-dependency-on-outside-approval-to-achieve-an-emotionally-free-high-performance-happy-life
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129344707
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339497
February 15, 2017
~ Additional patents are being filed in the MMJ space! ~
http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm
http://www.thedailychronic.net/2017/68842/clinical-trial-thcv-lowers-blood-sugar-levels-in-type-2-diabetics/
http://www.thedailychronic.net/2017/69698/study-medical-cannabis-patients-reduce-their-use-of-opioids/
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340717
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129277006
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022846
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129017714
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 21-23, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129368069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129312100
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311752
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129297007
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129296364
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129295215
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286262
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129196331
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128961948
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128957163
February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070
January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860
November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm
November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm
Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017
2dollarbill ~ REPOST
just doing my part here...
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher. Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.
1- back in 2.25.2014 philips manufactured there last fda approval of tetrastem, its a 3 year shelf life as im able to see
2 - in 5.28.2014 VDRM started to manufacture there first fda approval of tetrastem, same 3 year shelf life
3 - now heres where it make huge sense in 3.2014 VDRM gets the rights to manufacture tetrastem from phlips....1 month after they start there first manufacture of tetrastem
4 - the 3 - 6 - 9 month studies kick in in a huge way, and now VDRM as of 1.2017 manufactures 500,000 bottles for sale,
...basically they took what worked expanded on it and said this is huger than we thought
5 - 12.2016 VDRM files for uopdated Viabecline patent - which is purely application - so that means anyone, anywhere, anytime they use tetrastem - pure play on licensing application
6 - back in 2015 rumors started that both PFE and MRK and Endo pharma were looking at VDRM
7 - 2.2017 Dr Otiko to write a paper on diabetic ulcers showing massive results - which means all roads to viabecline
articles of interest ( get them off the web )
1 - from a 2.2011 study reposted in 1.2017 paraplegic uses tetrastem with stem cells and walks again ( philips put the article out )
2 - 3.2015 onychmycosis article
3 - 11.2016 viabecline article
4 - 12.2016 diabetic ulcers study vdrm issued
5 - 12.2016 viabecline patent applied for
6 - 1.2017 vdrm 500,000 bottles manufactured for 2017 grossing 62-65M in sales
viabecline is a delivery of tetrastem - which can take any oral as well and apply to ointment application
PFE is all about viagra, now imagine a lotion for f on f , not just a pill, and youve opened a huge market in the world away of same sex...mrk is all about diabetes and with application wise they want in too, add in JNJ which bandaids work and graduate to a 1000% increase in healing and they want in too...
VDRM product is 85% cheaper and works better - Viabecline is what the entire game is all about here - application technology
PFE Viagra is a category killer but it is a pill - and a pill is a introduction internally to the blood stream which out of fear a great portion of the population will just not take, now factor in a female Viagra alternative that is topical and replace the male Viagra with the same topical and its obvious that PFE will be forced to enter some sort of licensing agreement to hold onto there market share and as well look to capitalize on the female market as well ( m on f , and f on f ) there are those that will only use topical not internal
MRK, LLY and MNKD are the diabetic market and its huge - toenail fungal market - now add on a turnaround solution they have been needing for years, to treat at home foot infections ( home care largest market globally ) and that market alone is extraordinary with multiple companies all vying to be the dominant player and VDRM having the solution to license
JNJ marketplace is wounds - the band , now graduate it to the ability to speed the process up say 10 fold to heal any scrapes scratched wounds and to hold there market-share JNJ will be forced to enter some sort of licensing deal just to hold the line or risk crippling there empire quite easily
MRK and JNJ baldness market is in a level all itself, as its a do it yourself world we live in - add a just for men/ ladies crowd solution to expand into the baldness market and make that a CVS Walgreen's etc play for direct access more licensing
without even touching on the other markets there is exceptional growth here
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~Info on Dr. Chris Otiko, CEO of ViaDerma~
Radio interview from December 9, 2016. https://upticknewswire.com/viaderma-ceo-dr-chris-otiko-talks-active-treatments-for-diabetic-wounds/
https://www.linkedin.com/in/chris-ayo-otiko-80284b5/
https://www.linkedin.com/pulse/healing-diabetic-ulcers-viabecline-new-topical-antibiotic-otiko
https://www.barbadostoday.bb/2014/07/05/miracle-drug-for-diabetics/
http://www.neurogenx.com/testimonial/christopher-otiko-dpm-ceo-executive-medical-director/
https://www.ratemds.com/doctor-ratings/2334438/Dr-Christopher+A.-Otiko-Reseda-CA.html
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394138
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129356678
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129353170
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346970
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311397
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129294386
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283754
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129265204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129223612
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129222563
~Patent/Licensing/Manufacturing Info~
https://www.drugs.com/otc/129916/tetrastem.html
(licensed as Diabecline and Viabecline). Regardless of who owns or has the rights to the patent, ViaDerma has licensing rights, and has filed a new patent pending application for the transdermal system as per January 11, 2017 PR
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129289616
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282983
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129280927
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129279832
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273942
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273861
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129234169
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232328
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224588
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224450
investorshub.advfn.com/boards/read_msg.aspx?message_id=129224065
Interesting posts!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129413941
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129397880
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394039
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129392467
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386665
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129383996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129357204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129351881
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346142
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334810
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129329694
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129308249
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129278022
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129268497
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129200839
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129127030
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129126891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022830
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129011372
GLTA
LONG $VDRM
Totally agree percival77!
Lets see how our little peril plays out
$VDRM
LOL again! Smartest move is to be LONG!! BOOOOOM
.10-12+ coming EOD Friday
LOL!!! bahahaha you don't get invited to http://dfcon.com/ unless you have something pretty special!!
Read my sticky's above;)
KABOOOM
$VDRM
Investors don't even know how big ViaDerma's potential is!!
I don't know of any other stock with this much potential!!!
Look back here in a year..
$VDRM
READ this PR again very carefully!!
This is why we could see $$'s by EOY
http://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Receives-Provisional-Patent-Numbers-for-Its-FDA-Registered-Viabecline-and-Cannabis-Technologies--and-Seeks-to-Distribute-its-Products-with-a-Management--Marketing-and-Distribution-Company-in-Canada-to-Approved-International-Cannabis-Countries?id=153729&b=y
LOS ANGELES, CA--(Marketwired - March 20, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the President, Dr. Christopher Otiko has received the Provisional Patent number for two patents pending. The Cannabis Provisional Patent #62466209, a patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution. The second provisional patent #62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2017.
The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.
Company CEO Dr. Christopher Otiko is attending the Diabetic Foot Global Conference (DFCon 20017), at Baylor College of Medicine in Houston, Texas and on Friday 24th of March will present a poster abstract based on seven years of research treating patients with Viabecline. "In recent studies, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks. This effect is more pronounced in more severe wounds, and the effect is the same whether the wound is infected or not," said Dr. Otiko. "Our goal is to have Viabecline added to all diabetic foot ulcer treatment protocols."
"We are also continuing the clinical testing stages of an anti-aging topical solution, a topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido. The market for our many products is very promising. We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Otiko.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, Viabecline, uses an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD and THC with the delivery system was filed in 2017. The use of CBD is aimed at the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com
CONTACT INFORMATION
Dr. Christopher Otiko
Chief Executive Officer
Email: info@viadermalicensing.com
Investor Relations Phone number: 310-734-6111
Just wait until 100's of world class DOCS from all over the world see ViaDerma's technology on Friday!! Plus Institutional $$ starts pouring in!!
$$$$'s
$VDRM
Conference will be BIG for ViaDerma!! March 23-25, this week..
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
Sponsors
EDUCATIONAL GRANTS
This activity has been planned to be well-balanced, objective, and scientifically rigorous. Information and opinions offered by speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.
Texas Heart Institute, Office of Continuing Medical Education, along with Baylor College of Medicine, gratefully acknowledges the following companies for providing educational grant support for this activity
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
EXHIBITS, SYMPOSIA AND WORKSHOP SPONSORS
Support for this conference has been provided in part by the following exhibitor, symposium and workshop sponsors:
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
FRIENDS OF DFCON
8th International Symposium on the Diabetic Foot
First Nations Limb Preservation Foundation
Wound Healing Society/Wound Healing Foundation
Inquires: dfcon@bcm.edu
MONSTER RUN coming!! Just getting started!
Cannabis Provisional Patent #62466209, a provisional patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution.
Think about it, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks over its closest competitor. If tests results are similar to Viabecline, for the MMJ space, do you think any other product on the planet will be able to compete with them?
We are talking $$'s when this happens, or a big buyout!
www.marketwired.com/press-release/viaderma-receives-provisional-patent-numbers-its-fda-registered-viabecline-cannabis-otc-pink-vdrm-2203945.htm
ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries
The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed.
The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.
All these companies will want licensing agreements for the Cannabis Provisional Patent #62466209
Canopy Growth (TSX:WEED)
OrganiGram (TSXV:OGI)
THC Biomed Intl Ltd (CSNX:THC)
Maple Leaf Green World (TSXV:MGW)
Emerald Health Therapeutics (TSXV:EMH)
Tetra Bio-Pharma (CSNX:TBP)
PharmaCan Capital (TSXV:MJN)
Aphria (TSXV:APH)
Aurora Cannabis (CSNX:ACB)
Cannabix Technologies (CSNX:BLO)
Supreme Pharmaceuticals (CSNX:SL)
Mettrum Health (TSXV:MT)
MYM Nutraceuticals (CSE:MYM)
CannaRoyalty (CSE:CRZ)
Emblem (TSXV:EMC)
Liberty Leaf (CSE:LIB)
Valens GroWorks (CSE:VGW)
Marapharm Ventures (CSE:MDM)
Wildflower Marijuana (CSE:SUN)
True Leaf Pet (CSE:MJ)
Puf Ventures (CSE:PUF)
Cannabix (CSE:BLO)
$VDRM then click on LATEST
We are ALL OVER TWITTER!!
.10-12+ by EOD Friday
$VDRM
.10-12+ by end of Friday
$VDRM
LOL .10-.12+ COMING BOOOOOOM
$VDRM
.10-12+ post conference! Maybe even by Friday
Lets go $VDRM
GAPPER!! We should open at .05 or higher!
Our good DOC speaks on Friday, March 24!!
$VDRM
ViaDerma's time has come!! .10-12+ post conference, maybe this week!
~ 100's of DOCs from around the world will see what our good Doc has been researching, developing, for over 7 years!! And now has provisional pending patent application #'s to back it up! Look at the list of COMPANIES at DFCon!!! Huge!! Massive $$ will pour in!!
~ sales of 500,000 units at $125/ rolling out in 2017! Check PRs posted on my sticky above.
~ LOI signed with a Canadian company to roll out licensing/distribution... if results come in positive, we're taking multi $$'s!! Canada is one of the world leaders in the MMJ space! Google Canadian MJ companies!! Huge potential there!
BOOOOM time people! Ride the waves, I hate to predict but our 'little' company may not be so 'little' soon!!
$VDRM
Look at the companies in attendance! Let alone all the 100's of DOCs attending from all over the world!!
MASSIVE move coming !
Conference will be BIG for ViaDerma!! March 23-25, this week..
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
Sponsors
EDUCATIONAL GRANTS
This activity has been planned to be well-balanced, objective, and scientifically rigorous. Information and opinions offered by speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.
Texas Heart Institute, Office of Continuing Medical Education, along with Baylor College of Medicine, gratefully acknowledges the following companies for providing educational grant support for this activity
PLATINUM
Abbott Laboratories
BRONZE
Boston Scientific
Cardiovascular Systems, Inc.
Fashek Family Foundation
EXHIBITS, SYMPOSIA AND WORKSHOP SPONSORS
Support for this conference has been provided in part by the following exhibitor, symposium and workshop sponsors:
PLATINUM
Acelity
Abbott Vascular
BSN medical, Inc.
Integra LifeSciences
SILVER
Boston Scientific
Cook Medical
EO2 Concepts
W.L. Gore
MiMedx
NOVADAQ
Osiris Therapeutics
Tissue Regenix
Woundcare-Circle
BRONZE
Acell
Alliqua BioMedical
Anvil Orthotics
Arobella Medical LLC
Derma Sciences
Footbeat
Hanger Clinic
Herreen
Medela LLC
MedShape, Inc.
Misonix
MTF Wound Care
Organogenesis
Philips Volcano
Restorative Medical
RestorixHealth
Spectranetics
Siren Care
Stryker
FRIENDS OF DFCON
8th International Symposium on the Diabetic Foot
First Nations Limb Preservation Foundation
Wound Healing Society/Wound Healing Foundation
Inquires: dfcon@bcm.edu
Check out the latest $VDRM TWITTER feeds!!
Big gap up!!
$VDRM
LOL Prove it .10-12+ coming!!! BOOOOOOMM
Long $VDRM